Venture

NeuroSilica’s objective is to develop and commercialize a novel nanotechnology–based biocompatible implantable materials for biomedical applications such as Deep Brain Stimulation and Brain-Computer Interface.

NeuroSilica, Inc. Team:

Max Signaevsky